Advances in supportive care for multiple myeloma

Noopur S. Raje, Andrew J. Yee, G. David Roodman

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

As patients with multiple myeloma live longer, helping them live better through improvements in supportive care is equally as vital. Intrinsic to the disease are bone-related complications at presentation and over the course of illness. Bisphosphonates have been an important therapy for ameliorating the risk of skeletal-related events, and work is ongoing to determine their optimal schedule. Patients with multiple myeloma also encounter several challenges related to their treatment, including peripheral neuropathy, thrombotic complications, and infections. These challenges are being addressed through a better understanding of the risk factors for developing these complications and by mitigating these risks through better dosing schemas and prophylaxis.

Original languageEnglish (US)
Pages (from-to)502-511
Number of pages10
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume12
Issue number4
StatePublished - 2014

Fingerprint

Multiple Myeloma
Bone Diseases
Diphosphonates
Peripheral Nervous System Diseases
Appointments and Schedules
Therapeutics
Infection

ASJC Scopus subject areas

  • Oncology
  • Medicine(all)

Cite this

Advances in supportive care for multiple myeloma. / Raje, Noopur S.; Yee, Andrew J.; Roodman, G. David.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 12, No. 4, 2014, p. 502-511.

Research output: Contribution to journalArticle

@article{1d82c8eb31f142d787ea1b45e4675178,
title = "Advances in supportive care for multiple myeloma",
abstract = "As patients with multiple myeloma live longer, helping them live better through improvements in supportive care is equally as vital. Intrinsic to the disease are bone-related complications at presentation and over the course of illness. Bisphosphonates have been an important therapy for ameliorating the risk of skeletal-related events, and work is ongoing to determine their optimal schedule. Patients with multiple myeloma also encounter several challenges related to their treatment, including peripheral neuropathy, thrombotic complications, and infections. These challenges are being addressed through a better understanding of the risk factors for developing these complications and by mitigating these risks through better dosing schemas and prophylaxis.",
author = "Raje, {Noopur S.} and Yee, {Andrew J.} and Roodman, {G. David}",
year = "2014",
language = "English (US)",
volume = "12",
pages = "502--511",
journal = "Journal of the National Comprehensive Cancer Network : JNCCN",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "4",

}

TY - JOUR

T1 - Advances in supportive care for multiple myeloma

AU - Raje, Noopur S.

AU - Yee, Andrew J.

AU - Roodman, G. David

PY - 2014

Y1 - 2014

N2 - As patients with multiple myeloma live longer, helping them live better through improvements in supportive care is equally as vital. Intrinsic to the disease are bone-related complications at presentation and over the course of illness. Bisphosphonates have been an important therapy for ameliorating the risk of skeletal-related events, and work is ongoing to determine their optimal schedule. Patients with multiple myeloma also encounter several challenges related to their treatment, including peripheral neuropathy, thrombotic complications, and infections. These challenges are being addressed through a better understanding of the risk factors for developing these complications and by mitigating these risks through better dosing schemas and prophylaxis.

AB - As patients with multiple myeloma live longer, helping them live better through improvements in supportive care is equally as vital. Intrinsic to the disease are bone-related complications at presentation and over the course of illness. Bisphosphonates have been an important therapy for ameliorating the risk of skeletal-related events, and work is ongoing to determine their optimal schedule. Patients with multiple myeloma also encounter several challenges related to their treatment, including peripheral neuropathy, thrombotic complications, and infections. These challenges are being addressed through a better understanding of the risk factors for developing these complications and by mitigating these risks through better dosing schemas and prophylaxis.

UR - http://www.scopus.com/inward/record.url?scp=84900436216&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900436216&partnerID=8YFLogxK

M3 - Article

VL - 12

SP - 502

EP - 511

JO - Journal of the National Comprehensive Cancer Network : JNCCN

JF - Journal of the National Comprehensive Cancer Network : JNCCN

SN - 1540-1405

IS - 4

ER -